Funder: National Institutes of Health (NIH)

Due Dates: March 3, 2025 | November 14, 2025 (final deadline)

Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year. Estimated total program funding: $3,000,000.

Summary: Supports exploratory/developmental research to accelerate understanding and treatment of Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Key Information: Clinical trials are not allowed; applications must include relevant animal/cellular models or patient biospecimens/data.